Unified Patent Court (UPC) analytics are now available. Check here

Law FirmOpposition Filing Analysis

The comprehensive analysis of Maiwald opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Maiwald

Patent NumberTitleApplicantOpposition DateOpposition Company
EP3875085Edaravone Suspension For Oral AdministrationMITSUBISHI TANABE PHARMAMar 19, 2025MAIWALD
EP3490582Methods And Compositions For Treating MyelofibrosisACCELERON PHARMAMar 12, 2025MAIWALD
EP3559113Masterbatch CompositionBASELL POLIOLEFINE ITALIAMar 11, 2025BOREALIS
EP3923970Methods For Increasing Growth In Pediatric Subjects Having Cholestatic Liver DiseaseMIRUM PHARMACEUTICALSFeb 14, 2025SANDOZ
EP3941267Smoking Substitute SystemNERUDIAFeb 10, 2025PHILIP MORRIS
EP3606999Biologically Degradable FilmBIO TEC BIOLOGISCHE NATURVERPACKUNGENFeb 3, 2025NOVAMONT
EP3270966Combination Of Hdac Inhibitor And Anti-Pd-1 Antibody For Treatment Of CancerSYNDAX PHARMACEUTICALSJan 31, 2025MAIWALD
EP3582814Compounds And Methods For Treatment Of Inflammatory Bowel Disease With Extra-Intestinal ManifestationsARENA PHARMACEUTICALSJan 31, 2025MAIWALD
EP3215166Altering Gene Expression In Cart Cells And Uses ThereofTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIAJan 23, 2025MAIWALD
EP3335707Combinations Of A Muscarinic Receptor Antagonist And A Beta-2 Adrenoreceptor AgonistGLAXO GROUPJan 17, 2025SANDOZ